Cointime

Avraham Pharmaceuticals

company

About

Avraham Pharmaceuticals, a pharmaceutical company, develops novel products for the treatment and prevention of neurodegenerative disorders.

  • 11 - 50

Highlights

Total Funding Amount
$4.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$4.50M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease, supporting the development of its lead product candidate, ladostigil.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4.50M
Avraham Pharmaceuticals has raised a total of $4.50M in funding over 2 rounds. Their latest funding was raised on Sep 17, 2014 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 17, 2014 Series Unknown $4.50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Avraham Pharmaceuticals is funded by 1 investors. Integra LifeSciences are the most recent investors.
Investor Name Lead Investor Funding Round
Integra LifeSciences — Series Unknown
Cointime
เนื้อหา
บริษัท